Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2021 Jun 9;154(2):370–372. doi: 10.1002/ijgo.13749

SARS‐CoV‐2 congenital infection and pre‐eclampsia‐like syndrome in dichorionic twins: A case report and review of the literature

Natalia Abadía‐Cuchí 1, Sara Ruiz‐Martínez 1,2,, Marta Fabre 3, Purificación Mateo 1,4, María Remacha Sienes 1, Purificación Ventura Faci 2,5, Jessica Bueno Sancho 6, Rafael Benito 6,7, Cristina Paules 1,2,4
PMCID: PMC9087521  PMID: 34009656

Synopsis

Description of a case of probable transplacental transmission of severe acute respiratory syndrome coronavirus 2 to both twins and development of pre‐eclampsia‐like syndrome in the mother.

Keywords: COVID‐19, multiple pregnancy, pre‐eclampsia, SARS‐CoV‐2, twin pregnancy, vertical transmission


Although the route of transmission of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is mainly respiratory, vertical transmission seems possible. 1 We report the case of a woman with a dichorionic diamniotic twin pregnancy admitted to Hospital Clínico Universitario Lozano Blesa at 38+4 weeks of gestation due to severe pre‐eclampsia in the context of a SARS‐CoV‐2 infection (positive nasopharyngeal PCR; Viasure, CerTest Biotec., Zaragoza, Spain) with a probable transplacental transmission of the virus to both twins.

The patient presented with fever and high blood pressure (160/90 mmHg). Evolution of laboratory parameters is shown in Table 1. Given the diagnosis of severe pre‐eclampsia, the patient underwent an emergency cesarean section due to breech presentation of both babies, who were immediately handed to pediatricians in a separate room and admitted to the neonatal intensive care unit. Apgar scores were 6/4/8 and 2/3/8 at 1, 5 and 10 min, cord blood pH was 7.18 and 7.22, and birthweight was 2820 and 2845 g. Nasopharyngeal PCR for SARS‐CoV‐2 was performed in each twin, and both tested positive. Chest X‐ray of each twin was normal, and they remained asymptomatic. PCR for SARS‐CoV‐2 was also performed in two swabs taken deep in the thickness of both placentas, both resulting in positive results (cycle threshold 16.7/19.1 and 16.7/19.1).

TABLE 1.

Analytical and microbiological parameters in the mother and twins

Parameter Delivery Day 1 Day 2 Day 5 Day 8
Analytical findings (mother)
Blood pressure, mmHg 160/90 106/75 111/74 125/76 120/88
Temperature, ºC 38.0 36.3 36.0 36.0 36.4
Creatinine, mg/dl 1.19 1.34 0.85 0.77 0.67
AST, U/L 43 80 67 30 33
ALT, U/L 12 24 30 17 22
LDH, U/L 443 670 578 339 398
CRP, mg/L 70.7 37.4 3.0 27.9
Hemoglobin, g/dl 12.0 10.6 10.7 7.1 8.9
Hematocrit, % 34.8 31.5 32.0 20.9 26.1
Leukocytes, per mm3 5400 19 200 32 400 14 800 8600
Neutrophils, per mm3 (%) 4400 (80.7) 15 900 (82.6) 27 200 (83.9) 11 400 (76.2) 6200 (72.7)
Lymphocytes, per mm3 (%) 700 (12.4) 2400 (12.5) 3200 (10.0) 2400 (15.9) 1600 (19.1)
Platelets, per mm3 59 000 79 000 172 000 184 000 270 000
Ferritin, ng/ml 992 1585 692 547
D‐dimer, µg/L 3964 1072 1283 1639
Proteins in urine, g/L >2 0.16
Parameter Delivery Day 2 Day 3 Day 8 Day 19
Microbiological findings (mother)
Nasopharyngeal PCR (CT) Positive (21.3/18.7) Positive (33.5/34.3)
Anti‐SARS‐CoV−2 IgM (index) Positive (64.7) Positive
Anti‐SARS‐CoV−2 IgM (index) Negative (0.01) Negative (1.1) Positive (9.0)
Microbiological findings (first twin/second twin)
Nasopharyngeal PCR (CT) Negative/negative Negative/positive (27.3/30.6) Positive (30.2/30.7) Positive (19.5/19.2)/positive (17.7/17.4)
Anti‐SARS‐CoV−2 IgM (index) Negative (0.02)/negative (0.02)
Anti‐SARS‐CoV−2 IgG (index) Negative (0.01)/negative (0.01) Negative (0.01)/negative (0.01) Positive (6.0)/positive (6.0)

Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C‐reactive protein; CT, cycle threshold; IgG, immunoglobulin G; IgM, immunoglobulin M; LDH, lactate dehydrogenase; PCR, polymerase chain reaction.

Following delivery, the mother required treatment with oxygen and dexamethasone due to mild dyspnea. Chest X‐ray showed bilateral interstitial infiltrates. On the following day, blood parameters worsened and were compatible with HELLP syndrome (hemolysis, elevated liver, low platelets) (Table 1). The mother and babies were discharged 9 days after delivery.

Although this is a single case report and the amniotic fluid was not tested, the mother had no contact with the newborns after the cesarean section, making horizonal transmission unlikely.

We found 41 studies reporting infected neonates born to infected mothers. Among 95 cases identified, only 24 were delivered via cesarean section to mothers who tested positive for SARS‐CoV‐2 and were immediately separated at birth. Two of these reported placentas with a positive test result for SARS‐CoV‐2 with inflammatory histologic changes that were not found in noninfected controls. 2 , 3 Moreover, further studies have described the presence of intervillositis in the placentas of infected mothers, which is associated with adverse perinatal outcomes such as severe pre‐eclampsia, fetal growth restriction, and miscarriage. 4

It is important to highlight the maternal clinical features in the present case. All data led to a diagnosis of severe pre‐eclampsia. However, there is the possibility of a pre‐eclampsia‐like syndrome caused by SARS‐CoV‐2, which has been previously described. 5

To our knowledge, this is the first case of probable vertical transmission of SARS‐CoV‐2 to both twins. Moreover, the possibility that the mother could have developed a pre‐eclampsia‐like syndrome makes this case unique.

CONFLICTS OF INTEREST

The authors have no conflicts of interest.

AUTHOR CONTRIBUTIONS

NAC, SRM, and CP wrote the article. MRS and PMA critically reviewed and corrected the article. MFE critically reviewed and corrected the analytical findings. RBR and JBS provided and reviewed the microbiological parameters. PVF provided, reviewed, and corrected the article.

ACKNOWLEDGMENTS

CP and SRM were supported by a research grant from the Instituto de Salud Carlos III (CM18/00202, JR19/00006).

Abadía‐Cuchí N, Ruiz‐Martínez S, Fabre M, et al. SARS‐CoV‐2 congenital infection and pre‐eclampsia‐like syndrome in dichorionic twins: A case report and review of the literature. Int J Gynecol Obstet. 2021;154:370–372. 10.1002/ijgo.13749

REFERENCES

  • 1. Egloff C, Vauloup‐fellous C, Picone O, Mandelbrot L, Roques P. Evidence and possible mechanisms of rare maternal–fetal transmission of SARS‐CoV‐2. J Clin Virol. 2020;128:104447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Patanè L, Morotti D, Giunta MR, et al. Vertical transmission of coronavirus disease 2019: severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019–positive mothers and neonates at birth. Am J Obstet Gynecol MFM. 2020;2(3):100145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Kirtsman M, Diambomba Y, Poutanen SM, et al. Probable congenital sars‐cov‐2 infection in a neonate born to a woman with active sars‐cov‐2 infection. CMAJ. 2020;192(24):E647‐E650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Hosier H, Farhadian S, Morotti RA, et al. SARS‐CoV‐2 infection of the placenta. J Clin Invest. 2020;130(9):4947‐4953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Mendoza M, Garcia‐Ruiz I, Maiz N, et al. Pre‐eclampsia‐like syndrome induced by severe COVID‐19: a prospective observational study. BJOG. 2020;127(11):1374‐1380. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Gynaecology and Obstetrics are provided here courtesy of Wiley

RESOURCES